Clinical Trial Update: Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating gastrin to improve islet transplantation outcomes in people with Type 1 diabetes, currently in Phase 1/2 and recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Gastrin (gastrin)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: RECRUITING